0001104659-17-032106.txt : 20170512
0001104659-17-032106.hdr.sgml : 20170512
20170512075912
ACCESSION NUMBER: 0001104659-17-032106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170511
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001261249
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 POOR FARM ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540-1715
BUSINESS PHONE: 609-683-1880
MAIL ADDRESS:
STREET 1: 101 POOR FARM ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540-1715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Selman Renee
CENTRAL INDEX KEY: 0001677942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36464
FILM NUMBER: 17836440
MAIL ADDRESS:
STREET 1: 1111 LOCUST STREET - NUMBER 7H
CITY: PHILADELPHIA
STATE: PA
ZIP: 19107
4
1
a4.xml
4
X0306
4
2017-05-11
0
0001261249
AGILE THERAPEUTICS INC
AGRX
0001677942
Selman Renee
101 POOR FARM ROAD
PRINCETON
NJ
08540
0
1
0
0
Chief Commercial Officer
Common Stock
2017-05-11
4
P
0
53333
3.68
A
53333
D
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.46 to $3.75, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Scott M. Coiante, Attorney-in-Fact
2017-05-12